Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Belgian agri-tech firm Biotalys plans listing in Brussels

Stock MarketsJun 15, 2021 06:10
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. FILE PHOTO: Grapes affected by "noble rot", induced by the Botrytis fungus, are pictured during harvest at Chateau du Pavillon in Sainte-Croix-Du-Mont vineyard, France, October 22, 2018. REUTERS/Regis Duvignau/File Photo

BRUSSELS (Reuters) - Belgian agri-tech company Biotalys announced on Tuesday plans to list on Euronext Brussels in the coming weeks, hoping to entice investors with its biological alternatives to chemical pesticides.

The company, founded in 2013, is a spin-off from the Flanders Institute for Biotechnology and the agricultural counterpart to Belgian biopharmaceutical firm Ablynx, which Sanofi (PA:SASY) bought in 2018 for 3.9 billion euros ($4.7 billion).

Both use llama antibodies, which are smaller and easier to manipulate than human equivalents. Biotalys extracts proteins for use against fungi, bacteria and insects that attack crops, especially high-value fruit like grapes and strawberries.

Biotalys expects to secure U.S. regulatory approval in mid-2022 for its first product, Evoca, and sees a 2024 launch in the European Union, which aims to cut chemical pesticide use by 50% by 2030.

Biotalys has seven potential products it intends to launch over the next decade and estimates the market could be worth $4.8 billion as countries shift to greener forms of farming.

"That's why at Biotalys, we believe it's the right time to come out of the woods and to be really public and demonstrate the impact we can have to fulfil this requirement for innovation," Biotalys Chief Executive Patrice Selles said.

Selles declined to say how much money Biotalys planned to raise but said existing investors such as GIMV and Sofinnova Partners would participate in the flotation, proceeds of which would go towards research and business development.

New investors BNP Paribas (PA:BNPP) and Belgian state fund SFPI-FPIM had also committed to a combined 10 million euros.

The company sees future revenues from its own sales and future partnerships and, longer term, use of its technology in other fields, such as food preservation.

Selles said Biotalys' products were as effective as chemical equivalents and superior to microbial solutions currently on the market because, as neutral proteins, they do not depend on particular environmental conditions to work.

($1 = 0.8248 euros)

Belgian agri-tech firm Biotalys plans listing in Brussels

Related Articles

Airbus raises forecasts after strong first half
Airbus raises forecasts after strong first half By Reuters - Jul 29, 2021

PARIS (Reuters) -Europe's Airbus sharply raised its forecasts for full-year deliveries and earnings after reporting better-than-expected half-year results on Thursday. The world's...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email